PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia (J.D.M., H.S., K.P.).\', \'Clinical Hematology Department (J.D.M., H.S.), Alfred Hospital, Melbourne, Victoria, Australia.\', \'Department of Medicine, Monash University, Melbourne, Victoria, Australia (J.D.M., H.S., K.P.).\', \'Department of Cardiology (K.P.), Alfred Hospital, Melbourne, Victoria, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1161/CIRCRESAHA.120.317447
?:doi
?:hasPublicationType
?:journal
  • Circulation research
is ?:pmid of
?:pmid
?:pmid
  • 32586214
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.813
?:rankingScore_hIndex
  • 297
is ?:relation_isRelatedTo_publication of
?:title
  • The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all